Sanofi SA (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 235   

Articles published

SNY 46.81 +0.83 (1.81%)
price chart
Investor Alert: Lawsuit against Sanofi SA (ADR) (NYSE:SNY) alleges Misleading ...
The Shareholders Foundation announces that an investor, who purchased shares of Sanofi SA (ADR) (NYSE:SNY), filed a lawsuit over alleged violations of Federal Securities Laws by Sanofi SA in connection with certain allegedly false and misleading ...
Sanofi SA (ADR) (SNY) And Netflix, Inc. (NFLX) Executives Entangled In ...
When Sanofi SA (ADR) (NYSE:SNY) CEO Christopher Viehbacher was sacked recently, it was believed that the disagreement between him and the board was the reason of his unfortunate exit.
Whistleblower Lawsuit Accuses Sanofi SA (SNY), Ousted CEO Of Kickback ...
Sanofi SA (ADR) (NYSE:SNY) has found itself caught in a whistleblower lawsuit, where a former employee is accusing the company of funneling $34 million in kickbacks and incentive payments to various doctors and pharmacies, influencing them to prescribe ...
Related articles »  
Sanofi SA (SNY) Outsources Research Facility To Evotec (EVTCY)
Sanofi SA (ADR) (NYSE:SNY) is reportedly in exclusive talks with Hamburg-based Evotec AG (ADR) (OTCMKTS:EVTCY) to transfer its research operations in Toulouse, France to the German drug-maker.
Related articles »  
Stock to Watch: Sanofi SA (ADR) (NYSE:SNY)
[PRNewswire] Sanofi SA (ADR) (NYSE:SNY) announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental biologics license application (sBLA) for Fluzone Intradermal Quadrivalent vaccine.
Traders Alert-Sanofi (SNY), Zurich (ZURVY), Keryx (KERX), PAGNIE (CFRUY)  Techsonian (press release)
Related articles »  
Pfizer Inc. (NYSE:PFE), GlaxoSmithKline plc (ADR) (NYSE:GSK), Sanofi SA ...
Security analysts are predicting that in near future, some giant companies that have highest yields on their dividends may be forced to cut it and names which are rumoring in the markets are Pfizer Inc. (NYSE:PFE), GlaxoSmithKline plc (NYSE:GSK ...
Related articles »  
Sanofi SA (SNY) Continues Search For Head; Smith & Nephew (SNN) CEO Out ...
In an employee meeting, Smith & Nephew plc (ADR) (NYSE:SNN) Chief Executive Olivier Bohuon dismissed rumors of his plans to leave the medical-device maker to join Sanofi SA (ADR) (NYSE:SNY), as per reports from Bloomberg. This implies that Sanofi, ...
Stock's Buzzers: Sanofi SA (ADR)(NYSE:SNY), ONEOK, Inc.(NYSE:OKE), Kate ...  Techsonian (press release)
Related articles »  
Sanofi SA (SNY), Regeneron Pharmaceuticals (REGN) Eczema Drug Gets FDA ...
Sanofi SA (ADR) (NYSE:SNY) and its US-based partner Regeneron Pharmaceuticals Inc's (NASDAQ:REGN) jointly developed experimental drug dupilumab has been granted breakthrough therapy designation by the US Food and Drug Administration for use ...
Related articles »  
Sanofi SA (SNY) Gets FDA Nod For Priftin Tablets To Treat Latent TB Infection
Sanofi SA (ADR) (NYSE:SNY) announced before US markets opened for trading Tuesday that the US Food and Drug Administration (FDA) has approved its Priftin (rifapentine) tablets for the treatment of latent tuberculosis infection.
Sizzling News - Sanofi SA (NYSE:SNY), Kimberly Clark (NYSE:KMB), TD ...  Techsonian (press release)
Related articles »  
Sanofi Fires CEO Following Clash With Board
Sanofi SA (ADR) (SNY) announced today that the company's board has decided to oust Chief Executive Officer Christopher Viehbacher, finally putting the rumors to rest.
Sanofi Ousts CEO Christopher Viehbacher, Stock Down - Update  Nasdaq
Related articles »